Vlaykova Tatyana, Miteva Lyuba, Gulubova Maya, Stanilova Spaska
Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.
Int J Colorectal Dis. 2007 Oct;22(10):1209-15. doi: 10.1007/s00384-007-0305-z. Epub 2007 Apr 3.
Etiologically, the sporadic colorectal cancer (CRC) is a complex and multifactorial disease that is linked to both exogenic and endogenic factors. Accumulating evidence indicates that susceptibility to cancers, including CRC, is mediated by genetically determined differences in the effectiveness of detoxification of potential carcinogens. A member of the glutathione-S-transferase (GST) family, GSTP1, is an important candidate for involvement in susceptibility to carcinogen-associated CRC. An A-->G transition in exon 5 of the GSTP1 gene resulting in Ile(105)Val amino acid substitution has been identified. This change leads to alteration in catalytic efficiency of variant enzyme. The aim of the current study was to evaluate the influence of Ile(105)Val GSTP1 polymorphism on susceptibility to CRC.
The GSTP1 genotyping was conducted in a case-control study of 80 ethnic Bulgarian CRC patients and 126 unaffected controls using polymerase chain reaction restriction fragment length polymorphism method.
A statistically significant case-control difference in genotype frequencies was observed: 0.69 vs 0.54 for Ile/Ile, 0.22 vs 0.39 for Ile/Val, and 0.09 vs 0.07 for Val/Val (p = 0.049). The odds ratio (OR) for Val/Val was close to 1 (0.96, 95%CI: 0.35-2.66, p = 0.942), whereas the OR for Ile/Val was significantly lower, 0.45 (95%CI: 0.24-0.86, p = 0.016), compared to the referent Ile/Ile genotype. Although a prevalence of the GSTP1 variant allele-containing genotypes (Ile/Val or Val/Val) was found in controls than in patients (OR = 0.53, 95%CI: 0.30-0.96, p = 0.035), the allele frequencies did not show significant difference between cases and controls (p = 0.127).
Based on the obtained protective effect of Ile/Val GSTP1 genotype, we could suggest that Ile(105)Val GSTP1 polymorphism may play some role in susceptibility to CRC.
从病因学角度来看,散发性结直肠癌(CRC)是一种复杂的多因素疾病,与外源性和内源性因素均有关联。越来越多的证据表明,包括CRC在内的癌症易感性是由潜在致癌物解毒有效性的基因决定差异介导的。谷胱甘肽-S-转移酶(GST)家族成员GSTP1是参与致癌物相关CRC易感性的重要候选基因。已鉴定出GSTP1基因第5外显子中的A→G转换,导致Ile(105)Val氨基酸替换。这种变化导致变异酶催化效率的改变。本研究的目的是评估Ile(105)Val GSTP1多态性对CRC易感性的影响。
采用聚合酶链反应-限制性片段长度多态性方法,对80例保加利亚族CRC患者和126例未受影响的对照进行病例对照研究,进行GSTP1基因分型。
观察到基因型频率在病例组和对照组之间存在统计学显著差异:Ile/Ile为0.69对0.54,Ile/Val为0.22对0.39,Val/Val为0.09对0.07(p = 0.049)。与参照Ile/Ile基因型相比,Val/Val的比值比(OR)接近1(0.96,95%CI:0.35 - 2.66,p = 0.942),而Ile/Val的OR显著较低,为0.45(95%CI:0.24 - 0.86,p = 0.016)。虽然在对照组中发现含GSTP1变异等位基因的基因型(Ile/Val或Val/Val)的患病率高于患者(OR = 0.53,95%CI:0.30 - 0.96,p = 0.035),但病例组和对照组之间的等位基因频率没有显著差异(p = 0.127)。
基于所获得的Ile/Val GSTP1基因型的保护作用,我们可以认为Ile(105)Val GSTP1多态性可能在CRC易感性中起一定作用。